Comment on “Langmuir Adsorption Kinetics in Liquid Media: Interface Reaction Model”
ACS Omega · 14.07.2026 · 11 (27) · 40948-40950
DOI: 10.1021/acsomega.6c00921 ↗Kurz gefasst
Kommentar in der Zeitschrift ACS Omega, online erschienen am 26.06.2026. Verfasst von Md Mehedi Hasan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering and Energy Institute of Louisiana, University of Louisiana at Lafayette, Lafayette, Louisiana 70504, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The interface reaction approach (IRA) model was proposed to provide a method of determining the adsorption rate constant that is independent of operating parameters. This Comment provides a list of assumptions and observations during model development that resulted in dimensional inconsistencies, making the foundation of the model invalid. This necessitates model reformulations and re-evaluations of different adsorption systems to ascertain the claims of the published work.
Autor:innen und Institutionen
- Department of Chemical Engineering and Energy Institute of Louisiana, University of Louisiana at Lafayette, Lafayette, Louisiana 70504, United States.
ORCID-Profile: Emmanuel D Revellame
Zitieren
APA
Hasan, M. M., & Revellame, E. D. (2026). Comment on “Langmuir Adsorption Kinetics in Liquid Media: Interface Reaction Model”. ACS Omega, 11(27), 40948-40950. https://doi.org/10.1021/acsomega.6c00921
Vancouver
Hasan MM, Revellame ED. Comment on “Langmuir Adsorption Kinetics in Liquid Media: Interface Reaction Model”. ACS Omega. 2026;11(27):40948-40950. doi:10.1021/acsomega.6c00921
BibTeX
@article{Hasan2026,
author = {Hasan, Md Mehedi and Revellame, Emmanuel D},
title = {Comment on “Langmuir Adsorption Kinetics in Liquid Media: Interface Reaction Model”},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {27},
pages = {40948--40950},
doi = {10.1021/acsomega.6c00921}
}
EUVIMED